Ara
Toplam kayıt 3, listelenen: 1-3
Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker
(Cambridge Univ Press, 2017)
Objective: The product of the G72 gene is an activator of d-amino acid oxidase and has been suggested to play a role in the pathogenesis of schizophrenia. Increased G72 protein levels may be associated with disturbed ...
Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
(Dove Medical Press Ltd, 2013)
Background: Second generation antipsychotics (SGAs) are currently the most prescribed drugs in the treatment of schizophrenia. Despite their advantages, which include greater improvement in negative symptoms, cognitive ...
Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome
(Dove Medical Press Ltd, 2015)
Background: Brain-derived neurotrophic factor (BDNF) is a well-established neurotrophin that plays a role in the pathophysiology of numerous psychiatric disorders. Many studies have investigated the serum BDNF levels in ...